Peer Review History

Original SubmissionDecember 6, 2020
Decision Letter - Gabriele Oliva, Editor

PONE-D-20-38355Towards Effective Clinical Decision Support Systems: A Systematic ReviewPLOS ONE

Dear Dr. Hak,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 06 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Gabriele Oliva, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Please upload a new copy of Figures 1 and 2 as the detail is not clear. Please follow the link for more information: https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/

5. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Tables 1, 2, 3, 4 and 5 in your text; if accepted, production will need this reference to link the reader to the Table.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Two reviews were obtained, both suggesting minor edits to the paper. I agree with the reviewers' evaluation and I am recommending a minor revision of the paper.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The topic is quite relevant and important. Overall, the paper achieved its overall aim i.e. " to systematically review the extant empirical evidence on this topic, establish the status quo of the research, and propose an agenda for further studies" However, there are a number of issues with the methods and the reporting as documented below.

This paper provides an extensive literature review related to the key features that influences the development of effective CDSS.

Method:

• The authors argue that focused only on papers published in five online data sources. There are other resources such as valuable conferences that might be even more relevant to the study's purpose than those in grey literature.

• The search strategy is not comprehensive enough for a systematic review. The search strategy is apparently missing.

• In the information resources, it is stated that five online data sources that have a major impact on health information systems research were selected. On what basis are these five main sources (references)? Which reference (s)?

Discussion:

• The authors argue that none of the reviews have provided a global trend of a CDSS through a systematic review, but the reader might find this claim ambitious (Given that you have not searched the database anymore).

• In the discussion, in systematic review articles, the results of the article should be compared with other articles related to this paper.

The structuring of the discussion and conclusion presentation is not well-argued and not clear to me.

Please rewrite the conclusion. Start with the main findings which should contain an overview of the literature you studied.

Reviewer #2: The article carries out a systematic review of clinical decision support systems. In particular, they want to identify the articles dealing with this issue by highlighting the characteristics that distinguish them, also providing information on the purpose and the recipient.

Five open source online resources are considered. In addition, defined a methodology based on specific criteria: freely accessible articles, written in English, must provide medical support, media must be computer or technological. Two reviewers will analyze the title, abstract and keyword of the articles according to the parameters and will extract the most significant ones. The extracted elements will be read entirely and analyzed. In particular, four main features will be analyzed: the management and technical representations, technological characteristics of the system, the type of system and the integration of the system. The data were classified without providing an analysis of the analyzed characteristics and differences between the various solutions proposed. It also shows the trend of the distribution and the use of different methodologies not analyzing the data or providing a comment of the same.

Authors should express more clearly the choice of criteria and the analysis made. In addition, the differences and aspects highlighted by the collection should be highlighted and clarify.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Maryam Zahmatkeshan

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Reviewer #1:

First of all, we would like to thank for the comments and constructive suggestions that will certainly contribute to the enrichment of this study. In this revised version, we reinforce all the points suggested by the reviewer, especially in the methods and in the discussion part. The changes are highlighted in yellow in the revised manuscript with track changes version.

In the 'Information Sources' chapter, we reinforce the criteria that were applied to choose data sources, based on the Scimago ranking. The search strategy was also completed, reinforcing the filters and terms used for the search. We also combine the search strategy with the eligibility criteria. In the discussion part, we refer to other systematic review studies that address the Clinical Decision Support System (DSS), but that do not relate to the objective of this study. They tend to analyse the application/performance of DSS into specific clinical problems, while we intend to analyse and characterize DSS by their capacities supporting the phases decision making process.

In the Discussion and Conclusion chapters, we rewrote as suggested, presenting a clearer, literature-based structure. We hope that the changes made are as expected.

Reviewer #2:

First of all, we would like to thank for the comments and constructive suggestions that will certainly contribute to the enrichment of this study. In this revised version, we reinforce all the points suggested by the reviewer, especially in the methods part. The changes are highlighted in green in the revised manuscript with track changes version. In the Data Extraction and Management chapter, we describe all the information that was extracted from the reviewed articles. In addition, we highlighted what was expected to be found at each stage of the decision-making process. We included the list of conditions considered for classifying DSS according to these phases (Table 2). We hope that the changes made are as expected.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Gabriele Oliva, Editor

Towards Effective Clinical Decision Support Systems: A Systematic Review

PONE-D-20-38355R1

Dear Dr. Hak,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Gabriele Oliva, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Both reviewers recommend acceptance. I agree with their judgement and I recommend acceptance as well.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Authors have adequately addressed my comments raised in a previous round of review and my feel that this manuscript is now acceptable for publication.

With respect

Reviewer #2: The article carries out a systematic review of clinical decision support systems. In particular, they want to identify the articles dealing with this issue by highlighting the characteristics that distinguish them, also providing information on the purpose and the recipient.

Five open source online resources are considered. In addition, defined a methodology based on specific criteria: freely accessible articles, written in English, must provide medical support, media must be computer or technological. Two reviewers will analyze the title, abstract and keyword of the articles according to the parameters and will extract the most significant ones. The extracted elements will be read entirely and analyzed. In particular, four main features will be analyzed: the management and technical representations, technological characteristics of the system, the type of system and the integration of the system. Authors express clearly the choice of criteria and the analysis made. In addition, the differences and aspects highlighted by the collection are express.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Gabriele Oliva, Editor

PONE-D-20-38355R1

Towards Effective Clinical Decision Support Systems: A Systematic Review

Dear Dr. Hak:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Gabriele Oliva

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .